Company release April 4, 2017 at 10:15 EET FIT Biotech has demonstrated proof-of-concept of its gene delivery vector in cancer models FIT Biotech Oy ("Company") has met a major research milestone with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback